CHEK Share Price Performance
Recent CHEK News & Updates
No updates
Check-Cap Ltd. Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.15
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Check-Cap Ltd. Competitors
About CHEK
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Israeli Market Performance
- 7 Days: -2.4%
- 3 Months: 21.0%
- 1 Year: 63.4%
- Year to Date: 28.6%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. More promisingly, the market is up 65% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading